치매

A study of over 375,000 Finns has linked hospital treatment for severe infections like cystitis and pneumonia to a higher risk of developing dementia within five to six years. Researchers identified 29 conditions associated with at least a 20 percent increased risk, with infections playing a key role. The findings suggest that preventing such infections could help modify dementia risk.

2026년 03월 19일 AI에 의해 보고됨

High meat intake may reduce dementia risk for older people with genetic predisposition to Alzheimer's, per a Karolinska Institutet study. The study tracked over 2,100 individuals aged 60 and older for up to 15 years. Findings apply to carriers of specific apoe gene variants.

A long-term analysis of more than 200,000 UK Biobank participants found that diets with lower glycemic index values were associated with a lower risk of dementia, including Alzheimer’s disease and vascular dementia, while higher dietary glycemic load was tied to a higher risk.

2026년 01월 14일 AI에 의해 보고됨

A new study reveals that despite guidelines, about one in four Medicare beneficiaries with dementia continue to receive brain-altering medications linked to falls and confusion. Prescribing rates have declined overall from 20% to 16% between 2013 and 2021, but those with cognitive impairment face higher risks. Researchers highlight the need for better documentation and alternatives to improve care safety.

Prof KVS Hari, director of the Centre for Brain Research at IISc Bengaluru, emphasized digital biomarkers for early detection and prevention of dementia. He noted that India's rapidly aging population makes dementia a major public health challenge. The centre focuses on data collection and AI to understand disease progression in the Indian context.

2025년 12월 12일 AI에 의해 보고됨

알츠하이머 시험이 암 연구에서 영감을 받은 다중 표적 접근으로 전환 중이며, Novo Nordisk의 세마글루타이드 실패에도 불구하고. Eli Lilly의 Kisunla와 Eisai 및 Biogen의 Leqembi 두 약물만이 진행을 늦추기 위해 널리 승인됨. 이러한 진화는 뇌 퇴화 질환을 복잡한 시스템으로 간주하며, 전 세계적 영향 속에서 이를 멈추는 새로운 방법을 모색함.